United Biologics

Executive Summary

United Biologics, headquartered in San Diego, is a private company specializing in innovative vascular models and medical device solutions. Founded in 2015, the company leverages its proprietary AngioClear silicone technology to develop standard and customizable patient-specific models that enhance non-invasive procedures. With a focus on advancing medical training and procedural planning, United Biologics serves as a key partner for healthcare providers and device manufacturers seeking realistic, high-fidelity anatomical models. The company's certified expertise and commitment to innovation position it as a leader in the growing market for vascular simulation and medical device testing.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation AngioClear model60% success
• Q3 2026Strategic partnership with major medical device company40% success
• Q2 2027Expansion of product line into neurology/vascular simulation50% success